Launching a company in today’s competitive (and litigious) spatial biology market may seem risky. But the new company ...

An international research team headed by scientists at the University of Cambridge has grown hundreds of intestinal epithelial ...

Nature Medicine selected Mone Zaidi's work on FSH and body fat as one of the eight “Notable Advances” in biomedicine.

Huntington’s disease causes neurons in parts of the brain to gradually break down and die. The disease attacks areas of the ...

A first-in-man study, headed by teams at the Nuffield department of surgical sciences and the department of oncology, at the ...

Mixed signals impair communications of all sorts—including communications between immune cells struggling to fend off cancer.

The improved gene-editing approach combines prime editors with a more efficient recombinase to insert or substitute ...

As the aging population increases, the race to unpack the molecular understanding of aging heats up. The rapamycin (mTOR) ...

Several cell therapies have received approval from the U.S. Food and Drug Administration and there is significant excitement ...

AI's allure with investors is strong as ever as Nvidia (NVDA) hovers around $3 trillion in market capitalization while Tempus ...

There is a puzzling controversy in the gene editing community whirling around a comparison of two relatively new, very ...

Researchers say study marks the first time a synthetic antioxidant gel has been used to preserve function of transplanted ...